Document is current
Any future updates will be listed below
-
Authors
Zou, Jing
Xie, Xuping http://orcid.org/0000-0003-0918-016X
Fontes-Garfias, Camila R. http://orcid.org/0000-0002-1912-8413
Swanson, Kena A.
Kanevsky, Isis
Tompkins, Kristin
Cutler, Mark
Cooper, David
Dormitzer, Philip R.
Shi, Pei-Yong http://orcid.org/0000-0001-5553-1616
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (AI142759)
- License Information
-
More Information
Article History
Received: 15 January 2021
Accepted: 8 March 2021
First Online: 25 March 2021
Competing interests
: The authors declare that there are no competing interests. X.X. and P.-Y.S. have filed a patent on the reverse genetic system and reporter SARS-CoV-2. K.A.S., I.K., K.T., M.C., D.C., and P.R.D. are employees of Pfizer and may hold stock options. J.Z., X.X., C.R.F.G., and P.-Y.S. received compensation from Pfizer to perform the neutralization assay.
